---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-26-000050"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2026-08-04T20:22:22+00:00"
generated_at: "2026-08-04T20:23:08.758477+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# USANA Q2 net loss $21.4M on $223M sales; cuts FY guidance, records $29M Hiya impairment

## Summary
- Net loss of $21.4M (diluted EPS $(1.16)) vs net income of $9.7M ($0.52) a year ago; adjusted EPS $(0.07) vs $0.74.
- Recorded $29.1M non-cash goodwill impairment on Hiya; Hiya net sales fell 17% to $28M, subscribers down 17%.
- Core Nutritional net sales $192M (-4% YoY); active customers 384,000 (-8%).
- FY2026 guidance slashed: consolidated net sales now $910M (prev $925M-$1.0B), net loss $(11)M (prev $20M-$27M), adj. EPS $0.76 (prev $1.95-$2.29).
- Balance sheet: $169M cash, zero debt; no share repurchases in Q2; $34M remaining authorization.

## SEC filing metadata
- accession: 0000896264-26-000050
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2026-08-04T20:22:22+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626426000050/0000896264-26-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626426000050/usna-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-26-000050
- JSON: https://secwatch.observer/filing/0000896264-26-000050.json
- Plain text: https://secwatch.observer/filing/0000896264-26-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.